ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
诺诚健华
成交量:
- -
成交额:
- -
市值:
- -
市盈率:
- -
高:
- -
开:
- -
低:
- -
收:
- -
数据加载中...
总览
公司
新闻
公告
【异动股】诺诚健华-B(09969-HK)涨10.26%
金融界网站
·
2021-02-16
诺诚健华-B(09969)完成发行2.1亿股
智通财经
·
2021-02-10
诺诚健华-B(09969.HK)完成配售2.1亿股
格隆汇
·
2021-02-10
诺诚健华:投资者及其代名人已根据认购协议的条款及条件按每股认购股份14.4...
新浪财经
·
2021-02-10
诺诚健华拟引入高瓴资本作为战略投资者 今日收涨逾17%
金融界
·
2021-02-03
大幅增发新股,北京药企诺诚健华引入高瓴资本战略投资
腾讯自选股
·
2021-02-03
诺诚健华-B拟发行2.11亿股新股份,筹资30.41亿港元
犀牛之星
·
2021-02-03
【港股通】诺诚健华(09969)大涨逾20% 折价配股获高瓴资本认购1.92亿股
凤凰网港股
·
2021-02-03
诺诚健华-B盘中异动 早盘股价大涨22.13%
自选股智能写手
·
2021-02-03
<52周新高> 诺诚健华─B(09969)涨17.70%,现报18.500元,创52周新高
凤凰网港股
·
2021-02-03
【聪明钱】诺诚健华(09969)折让14.04%配售逾2.1亿股新股份 净筹30.4亿元
凤凰网港股
·
2021-02-03
诺诚健华:以每股14.45港元发行股份融资30.4亿港元
第一财经
·
2021-02-03
智信会客室-港股通标的+创新药黑马——诺诚健华-B在线交流
腾讯自选股
·
2021-01-27
诺诚健华-B盘中异动 大幅拉升5.08%
自选股智能写手
·
2021-01-20
诺诚健华-B盘中异动 股价大跌6.30%
自选股智能写手
·
2021-01-15
诺诚健华董事长兼CEO崔霁松:科学驱动创新,患者所需为本 | 医药生物2021思想录
腾讯自选股
·
2021-01-14
诺诚健华-B盘中异动 股价大跌5.03%报12.081港元
自选股智能写手
·
2021-01-11
诺诚健华CEO崔霁松:中国完全有可能在肿瘤领域做到世界领先
新浪财经
·
2020-12-10
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/90009/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90009","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":0,"timestamp":0,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":25034000,"shares":225290000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"06-06 14:45:22","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1749197400000},"marketStatusCode":2,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":24.34,"timestamp":1749192319000,"preClose":23.98,"halted":0,"volume":4549000,"delay":0,"premium":"-100.00"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","floatShares":25034000,"roa":"--","roe":"--","lyrEps":0,"shares":225290000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90009\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2111000415","title":"【异动股】诺诚健华-B(09969-HK)涨10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2111000415","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2111000415?lang=zh_cn&edition=fundamental","pubTime":"2021-02-16 10:50","pubTimestamp":1613443823,"startTime":"0","endTime":"0","summary":"【财华社讯】诺诚健华-B(09969-HK)截至10:50上涨10.26%,现报21.5港元,涨2港元。成交272万股,涉资5652万元。(出处:FinetAI)","market":"hk","thumbnail":"https://static.tigerbbs.com/c318bcd91a109139b7d70c76c30bb154","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c318bcd91a109139b7d70c76c30bb154"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/02/16105031953626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["90009","09969"],"gpt_icon":0},{"id":"2110157015","title":"诺诚健华-B(09969)完成发行2.1亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2110157015","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2110157015?lang=zh_cn&edition=fundamental","pubTime":"2021-02-10 19:12","pubTimestamp":1612955563,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺诚健华-B(09969)发布公告,认购协议的所有条件均已获达成,且认购事项于2021年2月10日完成。投资者及其代名人已根据认购协议的条款及条件按每股14.45港元的认购价认购合计2.1亿股。","market":"hk","thumbnail":"https://static.tigerbbs.com/239de6d52f53f295cfca7ca2933e727c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/239de6d52f53f295cfca7ca2933e727c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/411024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09969","90009"],"gpt_icon":0},{"id":"2110601590","title":"诺诚健华-B(09969.HK)完成配售2.1亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2110601590","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2110601590?lang=zh_cn&edition=fundamental","pubTime":"2021-02-10 19:07","pubTimestamp":1612955276,"startTime":"0","endTime":"0","summary":"格隆汇2月10日丨诺诚健华-B(09969.HK)发布公告,认购协议的所有条件均已获达成,且认购事项于2021年2月10日完成。投资者及其代名人已根据认购协议的条款及条件按每股认购股份14.45港元的认购价认购合共2.1亿股认购股份。","market":"us","thumbnail":"https://static.tigerbbs.com/4eb8717d5f99acf9a964a1268bca53d6","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/4eb8717d5f99acf9a964a1268bca53d6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/news/detail.html?id=484351","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_gelonghui","symbols":["90009","09969"],"gpt_icon":0},{"id":"2110456860","title":"诺诚健华:投资者及其代名人已根据认购协议的条款及条件按每股认购股份14.4...","url":"https://stock-news.laohu8.com/highlight/detail?id=2110456860","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2110456860?lang=zh_cn&edition=fundamental","pubTime":"2021-02-10 19:05","pubTimestamp":1612955149,"startTime":"0","endTime":"0","summary":"诺诚健华:投资者及其代名人已根据认购协议的条款及条件按每股认购股份14.45港元的认购价认购合共210,508,000股认购股份。","market":"sh","thumbnail":"https://static.tigerbbs.com/28009f8e87ba9680b5b94d59ba7ac119","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/28009f8e87ba9680b5b94d59ba7ac119"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2021-02-10/doc-ikftssap5237416.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2021-02-10/doc-ikftssap5237416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009"],"gpt_icon":0},{"id":"2108948796","title":"诺诚健华拟引入高瓴资本作为战略投资者 今日收涨逾17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2108948796","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108948796?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 18:29","pubTimestamp":1612348194,"startTime":"0","endTime":"0","summary":"诺诚健华拟引入高瓴资本作为战略投资者 今日收涨逾17% 来源:金融界金融界网2月3日消息今日早间,诺诚健华-B发布公告称,已与高瓴资本旗下Gaoling与YHG、维梧资本旗下Vivo OPPortunity Fund, L.P.签署认购协议,将以定增方式发行新股21050.8万股,募集资金总额约30.42亿港元。根据公告,此次新发行的股份,截至该公告日期约占诺诚健华现有已发行股份总额的16.33%,约占此次发行后股份总额的14.04%。今日早盘,诺诚健华高开近15%,截至收盘报18.40港元/股,上涨17.05%。","market":"us","thumbnail":"https://static.tigerbbs.com/d1a3ce387493b5d8207a7c7362ab1e56","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d1a3ce387493b5d8207a7c7362ab1e56"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-02-03/doc-ikftssap2754551.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-02-03/doc-ikftssap2754551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009"],"gpt_icon":0},{"id":"2108969947","title":"大幅增发新股,北京药企诺诚健华引入高瓴资本战略投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2108969947","media":"腾讯自选股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108969947?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 17:07","pubTimestamp":1612343220,"startTime":"0","endTime":"0","summary":"大幅增发新股,北京药企诺诚健华引入高瓴资本战略投资 来源:北京日报客户端2月3日北京生物医药高科技公司诺诚健华披露,其与高瓴资本以及维梧资本旗下的相关机构签署认购协议,由高瓴资本与维梧资本认购其定向增发的约2.1亿股新股份。而这一引入战略投资的行动也显示了资本市场对诺诚健华自主创新能力的认可。据介绍,这相当于截至当天诺诚健华现有已发行股份总额的约16.33%,认购价为每股14.45港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/890dd2dfb205aa8aa1d140672304b3c8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/890dd2dfb205aa8aa1d140672304b3c8"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-02-03/doc-ikftpnny3709207.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-02-03/doc-ikftpnny3709207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009"],"gpt_icon":0},{"id":"2108969117","title":"诺诚健华-B拟发行2.11亿股新股份,筹资30.41亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2108969117","media":"犀牛之星","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108969117?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 12:56","pubTimestamp":1612328160,"startTime":"0","endTime":"0","summary":"诺诚健华-B拟发行2.11亿股新股份,筹资30.41亿港元 来源:犀牛之星2月3日,诺诚健华-B宣布,于2月2日,公司与投资者订立两份认购协议,据此,公司已有条件同意配发及发行且投资者已有条件同意按个别但非共同基准认购合共2.11亿股新股份,相当于公司现有已发行股份总额的约16.33%,及经配发及发行认购股份而扩大之公司已发行股份总额的约14.04%,认购价为每股认购股份14.45港元,较联交所于2月2日所报收市价每股15.72港元折让约8.08%。","market":"sh","thumbnail":"https://static.tigerbbs.com/e9c35ed98221796867ee3eb028c7fe9e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e9c35ed98221796867ee3eb028c7fe9e"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-02-03/doc-ikftssap2612843.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-02-03/doc-ikftssap2612843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009","09969"],"gpt_icon":0},{"id":"2108557867","title":"【港股通】诺诚健华(09969)大涨逾20% 折价配股获高瓴资本认购1.92亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2108557867","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108557867?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 09:41","pubTimestamp":1612316494,"startTime":"0","endTime":"0","summary":"凤凰网港股|诺诚健华(09969)今日股价跳空高开逾14%,随后涨幅扩大,最高曾升至20元,创上市新高,最新报18.66元,涨18.7%,成交额8595万元。集团公布,计划配售2.11亿股股份,占扩大后股本14.04%,每股配售价为14.45元,较昨日收市价折让8.08%。据悉,投资者包括HillhouseCapital认购1.91613亿股,已持股8.08%的VivoCapitalLLC认购1889.5万股,紧随完成后,HillhouseCapital持股12.77%,而VivoCapitalLLC持股8.2%;股份有365天禁售期。","market":"hk","thumbnail":"https://static.tigerbbs.com/890dd2dfb205aa8aa1d140672304b3c8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/890dd2dfb205aa8aa1d140672304b3c8"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102030941467e60413e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102030941467e60413e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2108755782","title":"诺诚健华-B盘中异动 早盘股价大涨22.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2108755782","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108755782?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 09:31","pubTimestamp":1612315871,"startTime":"0","endTime":"0","summary":"2021年02月03日早盘09时31分,诺诚健华-B股票出现波动,股价快速上涨22.13%。诺诚健华-B股票所在的生物技术行业中,整体涨幅为2.24%。消息层面,截至09时31分,诺诚健华-B股票正面舆情新闻比例88.24%。该信息摘要如下:2月3日消息,诺诚健华拟折让8%配股,今日股价高开近15%,报18.06港元。诺诚健华公布,计划配售2.11亿股股份,占扩大后股本14.04%,当中高瓴资本认购1.92亿股、维梧资本认购1,889.5万股;每股配售价为14.45元,较昨日收市价折让8.08%。","market":"hk","thumbnail":"https://static.tigerbbs.com/60ffa9c348f2ccdef831ec338d80994f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/60ffa9c348f2ccdef831ec338d80994f"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102030931147e604085&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102030931147e604085&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["90009","09969"],"gpt_icon":0},{"id":"2108755785","title":"<52周新高> 诺诚健华─B(09969)涨17.70%,现报18.500元,创52周新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2108755785","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108755785?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 09:30","pubTimestamp":1612315823,"startTime":"0","endTime":"0","summary":"凤凰网港股| 截至09:30 诺诚健华─B(09969)较昨收价涨17.70%,现报18.500元,创52周新高;成交量52.50万股,成交额948.15万港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210203093028786da5b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210203093028786da5b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2108781755","title":"【聪明钱】诺诚健华(09969)折让14.04%配售逾2.1亿股新股份 净筹30.4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2108781755","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108781755?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 08:53","pubTimestamp":1612313580,"startTime":"0","endTime":"0","summary":"凤凰网港股|诺诚健华公布,集团配售2.10508亿股新股份,占扩大后股本14.04%。每股配售价格14.45元,较上日收市价15.72元折让8.08%。据悉,投资者包括HillhouseCapital认购1.91613股,已持股8.08%的VivoCapitalLLC认购1889.5万股,紧随完成后,HillhouseCapital持股12.77%,而VivoCapitalLLC持股8.2%;股份有365天禁售期。","market":"hk","thumbnail":"https://static.tigerbbs.com/bde7ae9d5c597eb01bbb4658f0573654","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bde7ae9d5c597eb01bbb4658f0573654"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102030853067c0479e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102030853067c0479e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2108755738","title":"诺诚健华:以每股14.45港元发行股份融资30.4亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2108755738","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2108755738?lang=zh_cn&edition=fundamental","pubTime":"2021-02-03 08:42","pubTimestamp":1612312920,"startTime":"0","endTime":"0","summary":"诺诚健华在港交所公告,与投资者订立两份认购协议,据此,本公司已有条件同意配发及发行且投资者已有条件同意按个别但非共同基准认购合共2.105亿股新股份,相当于截至本公告日期本公司现有已发行股份总额的约16.33%,及经配发及发行认购股份而扩大之本公司已发行股份总额的约14.04%(假设完成前并无发行其他股份),认购价为每股认购股份14.45港元,融资30.4亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/bde7ae9d5c597eb01bbb4658f0573654","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bde7ae9d5c597eb01bbb4658f0573654"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210203084350786da25d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210203084350786da25d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2106283817","title":"智信会客室-港股通标的+创新药黑马——诺诚健华-B在线交流","url":"https://stock-news.laohu8.com/highlight/detail?id=2106283817","media":"腾讯自选股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2106283817?lang=zh_cn&edition=fundamental","pubTime":"2021-01-27 11:28","pubTimestamp":1611718109,"startTime":"0","endTime":"0","summary":"智信会客室-港股通标的+创新药黑马——诺诚健华-B在线交流 来源:智远资讯2021年1月27日(星期三)16:30,港股通标的+创新药黑马——诺诚健华-B将在智信云路演平台进行在线交流!截至1月22日,港股通持股比例1.26%。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-01-27/doc-ikftssap1249956.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-01-27/doc-ikftssap1249956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["09969","90009","06978","90014","159992"],"gpt_icon":0},{"id":"2104023281","title":"诺诚健华-B盘中异动 大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2104023281","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2104023281?lang=zh_cn&edition=fundamental","pubTime":"2021-01-20 09:53","pubTimestamp":1611107605,"startTime":"0","endTime":"0","summary":"2021年01月20日早盘09时53分,诺诚健华-B股票出现异动,股价急速拉升5.08%。截至发稿,该股报14.061港元/股,成交量116.5万股,换手率0.09%,振幅4.19%。诺诚健华-B股票所在的生物技术行业中,整体涨幅为5.70%。其相关个股中,康方生物-B、亚盛医药-B、康希诺生物-B涨幅较大,振幅较大的相关个股有康方生物-B、亚盛医药-B、锦欣生殖,振幅分别为12.03%、4.61%、4.32%。诺诚健华-B公司简介:诺诚健华医药有限公司是一家主要从事生物医药业务的投资控股公司。","market":"hk","thumbnail":"https://static.tigerbbs.com/528f1b5f95c1aa85d740d858963e7e8f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/528f1b5f95c1aa85d740d858963e7e8f"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210120095326786a1dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210120095326786a1dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2103193901","title":"诺诚健华-B盘中异动 股价大跌6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2103193901","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2103193901?lang=zh_cn&edition=fundamental","pubTime":"2021-01-15 09:30","pubTimestamp":1610674223,"startTime":"0","endTime":"0","summary":"2021年01月15日早盘09时30分,诺诚健华-B股票出现异动,股价大幅下挫6.30%。截至发稿,该股报12.501港元/股,成交量1976.6万股,换手率1.53%,振幅2.10%。诺诚健华-B股票所在的生物技术行业中,整体涨幅为1.96%。消息层面,截至09时30分,诺诚健华-B股票正面舆情新闻比例25%。该信息摘要如下:凤凰网港股|诺诚健华今日股价平开高走,最新报12.64元,涨4.81%,成交额443.3万元。","market":"hk","thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210115093023786908fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210115093023786908fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2103185032","title":"诺诚健华董事长兼CEO崔霁松:科学驱动创新,患者所需为本 | 医药生物2021思想录","url":"https://stock-news.laohu8.com/highlight/detail?id=2103185032","media":"腾讯自选股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2103185032?lang=zh_cn&edition=fundamental","pubTime":"2021-01-14 07:27","pubTimestamp":1610580442,"startTime":"0","endTime":"0","summary":"诺诚健华董事长兼CEO崔霁松:科学驱动创新,患者所需为本 | 医药生物2021思想录 来源:金融界网编者按:医药生物产业能否迎来翘首以盼的科研与应用黄金时代?诺诚健华联合创始人、董事长兼首席执行官崔霁松在新年致辞中表示,2020年是极为特殊的一年,对诺诚健华来说也是意义非凡的一年。这一年,诺诚健华坚持不懈,一往无前,不断突破,勇于创新。2021年,诺诚健华将继续秉承“科学驱动创新,患者所需为本”的理念,砥砺前行。","market":"sh","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-01-14/doc-ikftssan5857687.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-01-14/doc-ikftssan5857687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["000808.SH","90009","163118"],"gpt_icon":0},{"id":"2102699606","title":"诺诚健华-B盘中异动 股价大跌5.03%报12.081港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2102699606","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2102699606?lang=zh_cn&edition=fundamental","pubTime":"2021-01-11 13:56","pubTimestamp":1610344595,"startTime":"0","endTime":"0","summary":"2021年01月11日下午盘13时56分,诺诚健华-B股票出现波动,股价大幅下挫5.03%。截至发稿,该股报12.081港元/股,成交量186.7万股,换手率0.14%,振幅6.92%。资金方面,该股资金流入712.54万港元,流出1365.37万港元。诺诚健华-B股票所在的生物技术行业中,整体涨幅为6.11%。消息层面,截至13时56分,《诺诚健华-B和镁信健康达成商保创新战略合作》资讯为影响诺诚健华-B的重要信息。","market":"hk","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202101111356367b6a1739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202101111356367b6a1739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2090185529","title":"诺诚健华CEO崔霁松:中国完全有可能在肿瘤领域做到世界领先","url":"https://stock-news.laohu8.com/highlight/detail?id=2090185529","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2090185529?lang=zh_cn&edition=fundamental","pubTime":"2020-12-10 18:27","pubTimestamp":1607596021,"startTime":"0","endTime":"0","summary":"在峰会访谈环节,诺诚健华联合创始人、董事长兼CEO崔霁松发表了自己的看法。崔霁松认为,中国的医药市场在过去五年发生了很大的变化。崔霁松表示,中国一些初创企业可能非常非常小,甚至只有几百人,但是他们在自身领域做的非常领先,也可以研发出来很好的药。谈到未来中国肿瘤领域发展,崔霁松认为中国完全有可能做到世界领先。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/hy/hyjz/2020-12-10/doc-iiznezxs6241595.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/hy/hyjz/2020-12-10/doc-iiznezxs6241595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90009\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90009\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90009\",market:\"HK\",delay:false,,,undefined,":{}}}